• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination: Correspondence.

作者信息

Mungmunpuntipantip Rujittika, Wiwanitkit Viroj

机构信息

Private Academic Consultant, Bangkok, Thailand.

Adjunct professor, Joseph Ayobabalola University, Ikeji-Arakeji, Nigeria; Honorary professor, Dr DY Patil University, Pune, India; visiting professor, Hainan Medical University, Haikou, China.

出版信息

Inflamm Bowel Dis. 2023 Mar 1;29(3):e7. doi: 10.1093/ibd/izac257.

DOI:10.1093/ibd/izac257
PMID:36579751
Abstract
摘要

相似文献

1
Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination: Correspondence.接受抗 TNF 治疗的炎症性肠病患者与 COVID-19 疫苗接种：通信
Inflamm Bowel Dis. 2023 Mar 1;29(3):e7. doi: 10.1093/ibd/izac257.
2
Reply to "Patients With Inflammatory Bowel Disease on Anti-TNF Therapy and COVID-19 Vaccination".对《接受抗TNF治疗的炎症性肠病患者与COVID-19疫苗接种》的回复
Inflamm Bowel Dis. 2023 Mar 1;29(3):e8-e9. doi: 10.1093/ibd/izad006.
3
Anti-tumor necrosis factor therapy is associated with attenuated humoral response to SARS-COV-2 vaccines in patients with inflammatory bowel disease.抗肿瘤坏死因子治疗与炎症性肠病患者对 SARS-CoV-2 疫苗的体液免疫应答减弱相关。
Vaccine. 2023 Jun 13;41(26):3862-3871. doi: 10.1016/j.vaccine.2023.05.012. Epub 2023 May 8.
4
Reduced Serological Response to COVID-19 Vaccines in Patients with IBD is Further Diminished by TNF Inhibitor Therapy; Early Results of the VARIATION study [VAriability in Response in IBD Against SARS-COV-2 ImmunisatiON].炎症性肠病患者对 COVID-19 疫苗的血清学反应降低，而 TNF 抑制剂治疗进一步降低；VARIATION 研究的早期结果 [针对 SARS-COV-2 免疫的 IBD 反应变异性]。
J Crohns Colitis. 2022 Sep 8;16(9):1354-1362. doi: 10.1093/ecco-jcc/jjac029.
5
Seroconversion Following SARS-CoV-2 Infection or Vaccination in Pediatric IBD Patients.儿童炎症性肠病患者感染或接种SARS-CoV-2后的血清转化
Inflamm Bowel Dis. 2021 Oct 20;27(11):1862-1864. doi: 10.1093/ibd/izab194.
6
Humoral Immune Response to Messenger RNA COVID-19 Vaccines Among Patients With Inflammatory Bowel Disease.炎症性肠病患者对新型冠状病毒mRNA疫苗的体液免疫反应
Gastroenterology. 2021 Oct;161(4):1340-1343.e2. doi: 10.1053/j.gastro.2021.06.016. Epub 2021 Jun 15.
7
COVID-19 Vaccines in IBD Patients: Particularities and Future Perspectives.炎症性肠病患者的新冠疫苗：特殊性与未来展望
J Crohns Colitis. 2022 Sep 8;16(9):1343-1344. doi: 10.1093/ecco-jcc/jjac042.
8
Response to COVID-19 vaccine is reduced in patients with inflammatory bowel disease, but improved with additional dose.炎症性肠病患者对 COVID-19 疫苗的反应降低，但增加剂量可改善。
J Gastroenterol Hepatol. 2023 Jan;38(1):44-51. doi: 10.1111/jgh.16001. Epub 2022 Sep 21.
9
Antibody response to the BNT162b2 SARS-CoV-2 vaccine in paediatric patients with inflammatory bowel disease treated with anti-TNF therapy.接受抗TNF治疗的炎症性肠病儿科患者对BNT162b2新冠病毒疫苗的抗体反应。
Gut. 2022 Sep;71(9):1922-1924. doi: 10.1136/gutjnl-2021-326196. Epub 2021 Nov 23.
10
The gut microbiota and metabolome are associated with diminished COVID-19 vaccine-induced antibody responses in immunosuppressed inflammatory bowel disease patients.肠道微生物组和代谢组与免疫抑制性炎症性肠病患者 COVID-19 疫苗诱导的抗体反应减弱有关。
EBioMedicine. 2023 Feb;88:104430. doi: 10.1016/j.ebiom.2022.104430. Epub 2023 Jan 10.